GH Therapy and first final height data in Noonan-like syndrome with loose anagen hair (Mazzanti syndrome)

American Journal of Medical Genetics, Part A

Volumn 161, Issue 11, 2013, Pages 2756-2761

  Mazzanti, Laura ^a   Tamburrino, Federica ^a   Scarano, Emanuela ^a   Perri, Annamaria ^a   Vestrucci, Benedetta ^a   Guidetti, Monica ^a   Rossi, Cesare ^a   Tartaglia, Marco ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Growth hormone; Noonan syndrome; NS LAH; Rasopathies; SHOC2

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BODY HEIGHT; CATCH UP GROWTH; CHILD; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; GENE; GENE MUTATION; GROWTH HORMONE DEFICIENCY; GROWTH RATE; HETEROZYGOSITY; HORMONAL THERAPY; HUMAN; HYPOTHALAMUS HYPOPHYSIS GONAD SYSTEM; LONG TERM CARE; LOOSE ANAGEN HAIR SYNDROME; MALE; MALFORMATION SYNDROME; MAZZANTI SYNDROME; MISSENSE MUTATION; NOONAN SYNDROME; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD; SHOC2 GENE; TREATMENT DURATION; TREATMENT OUTCOME;

GROWTH HORMONE; NOONAN SYNDROME; NS/LAH; RASOPATHIES; SHOC2;

BODY HEIGHT; CHILD; CHILD, PRESCHOOL; FEMALE; GROWTH CHARTS; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; INFANT; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LOOSE ANAGEN HAIR SYNDROME; MALE; MUTATION; NOONAN SYNDROME; PHENOTYPE; PUBERTY;

EID: 84886245228     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.36255     Document Type: Article

References (21)

1. Binder G, Neuer K, Ranke MB, Wittekindt NE. 2005. PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan Syndrome. J Clin Endocrinol Metab 90:5377-5381.
2. Cacciari E, Milani S, Balsamo A, Spada E, Bona G, Cavallo L, Cerutti F, Gargantini L, Greggio N, Tonini G, Cicognani A. 2006. Italian cross-sectional growth charts for height, weight and BMI (2 to 20 yr). J Endocrinol Invest 29:581-593.
3. Capalbo D, Melis D, De Martino L, Palamaro L, Riccomagno S, Bona G, Cordeddu V, Pignata C, Salerno M. 2012a. Noonan-like syndrome with loose anagen hair associated with growth hormone insensitivity and atypical neurological manifestation. Am J Med Genet Part A 158A:856-860.
4. Capalbo D, Scala MG, Melis D, Minopoli G, Improda N, Palamaro L, Pignata C, Salerno M. 2012b. Heterogeneity in two patients with Noonanlike Syndrome associated with the same SHOC2 mutation. Ital J Pediatr 38:48.
5. Cordeddu V, Di Schiavi E, Pennacchio LA, Ma'ayan A, Sarkozy A, Fodale V, Cecchetti S, Cardinale A, Martin J, Schackwitz W. et al. 2009. Mutation of SHOC2 promotes aberrant protein N-myristoylation and causes Noonan-like syndrome with loose anagen hair. Nat Genet 41:1022-1026.
6. Dahlgren J. 2009. GH therapy in Noonan syndrome. Horm Res 72:46-48.
7. De Rocca Serra-Nédélec A, Edouard T, Tréguer K, Tajan M, Araki T, Dance M, Mus M, Montagner A, Tauber M, Salles JP, Valet P, Neel BG, Raynal P, Yart A. 2012. Noonan syndrome-causing SHP2 mutants inhibit insulin-like growth factor 1 release via growth hormone-induced ERK hyperactivation, which contributes to short stature. PNAS 109:4257-4262.
8. Ferreira LV, Souza ALS, Arnhold IJP, Mendoca BB, Jorge AAL. 2005. PTPN11 (Protein tyrosine phosphatise non receptor type 11) mutations and response to growth hormone therapy in children with Noonan Syndrome. J Clin Endocrinol Metab 90:5156-5160.
9. Kirk JM, Betts PR, Butler GE, Donaldson MD, Dunger DB, Johnston DI, Kelnar CJ, Price DA, Wilton P. 2001. Short stature in Noonan syndrome: Response to growth hormone therapy. Arch Dis Child 84:440-443.
10. Lee PA, Ross J, Germak JA, Gut R. 2012. Effect of 4 years of growth hormone therapy in children with Noonan syndrome in the American Norditropin Studies: Web-enabled research (ANSWER) program(R) registry. Int J Pediatr Endocrinol 2012:15.
11. Limal JM, Parfait B, Cabrol S, Bonnet D, Leheup B, Lyonnet S, Vidaud M, Le Bouc Y. 2006. Noonan syndrome: Relationships between genotype, growth, and growth factors. J Clin Endocrinol Metab 91:300-336.
12. Malaquias AC, Brasil AS, Pereira AC, Arnhold IJP, Mendonca BB, Bertola DR, Jorge AAL. 2012. Growth standards of patients with Noonan and Noonan-like syndromes with mutations in the RAS/MAPK pathway. Am J Med Genet Part A 158A:2700-2706.
13. Mazzanti L, Cacciari E, Cicognani A, Bergamascgi R, Scarano E, Forabosco A. 2003. Noonan-like syndrome with loose anagen hair: A new syndrome?. Am J Med Genet A 118A:279-286.
14. Mazzanti L, Tamburrino F, Bergamaschi R, Scarano E, Montanari F, Torella M, Ballarini E, Cicognani A. 2009. Developmental syndromes: growth hormone deficiency and treatment. Endocr Dev 14:114-134.
15. Noordam C, van der Burgt I, Sweep CG, Delemarre-van de Waal HA, Sengers RC, Otten BJ. 2001. Growth hormone (GH) secretion in children with Noonan syndrome: Frequently abnormal without consequences for growth or response to GH treatment. Clin Endocrinol (Oxf) 54:53-59.
16. Osio D, Dahlgren J, Albertsson Wikland K, Westphal O. 2005. Improved final height with long-term growth hormone treatment in Noonan syndrome. Acta Paediatr 94:1232-1237.
17. Otten J, Noordam K. 2007. Short stature in Noonan Syndrome: Results of growth hormone treatment. In: Ranke MB, Price DA, Reiter EO, editors. Growth Hormone in Pediatrics-20 years of KIGS. Basel: Karger, p 347-355.
18. Padidela R, Camacho-Hübner C, Attie KM, Savage MO. 2008. Abnormal growth in Noonan syndrome: Genetic and endocrine features and optimal treatment. Horm Res 70:129-136.
19. Ranke MB, Heidemann P, Knupfer C, Enders H, Schmaltz AA, Bierich JR. 1988. Noonan syndrome: Growth and clinical manifestations in 144 cases. Eur J Pediatr 148:220-227.
20. Romano AA, Dana K, Bakker B, Davis DA, Hunold JJ, Jacobs J, Lippe B. 2009. Growth response, near-adult height, and patterns of growth and puberty in patients with Noonan syndrome treated with growth hormone. J Clin Endocrinol Metab 94:2338-2344.
21. Tartaglia M, Gelb BD. 2010. Disorders of disregulated signal traffic through the RAS-MAPK pathway: Phenotypic spectrum and molecular mechanisms. Ann N Y Acad Sci 1214:99-121.